UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
MSD Korea, Mundipharma Korea in mandatory work-from-home mode, again
MSD Korea and Mundipharma Korea ordered their employees to work from home a...
by Kim Yun-mi
|
2020-05-12 11:57
라인
SGLT-2 inhibitor’s renal function benefit recognized limitedly
Long-term sodium-glucose transport protein-2 (SGLT-2) inhibitor treatments ...
by Kim Yun-mi
|
2020-05-11 14:48
라인
‘Roche’s Kadcyla allows early breast cancer patients to continue social life’
Roche Korea obtained additional indication approval for Kadcyla (ingredient...
by Kim Yun-mi
|
2020-05-08 15:51
라인
‘Government should stock Covid-19 vaccines even after virus disappears’
“To develop a vaccine for the new coronavirus infection, it is important to...
by Kim Yun-mi
|
2020-05-07 16:43
라인
US expert notices Korea’s response to Covid-19 outbreak at call center
A report by the Korean Centers for Disease Control and Prevention on its re...
by Kim Yun-mi
|
2020-05-06 15:48
라인
New law takes effect to spur growth of in vitro diagnostic devices
The government said it would promote the growth of in vitro diagnostic medi...
by Kim Yun-mi
|
2020-05-01 15:35
라인
‘Keytruda alone works as first-line therapy for lung cancer’
MSD’s immunotherapy Keytruda (ingredient: pembrolizumab) should be a standa...
by Kim Yun-mi
|
2020-04-29 11:40
라인
Researchers start testing pancreatitis drug to fight Covid-19
The Ministry of Food and Drug Safety has approved a local investigator-init...
by Kim Yun-mi
|
2020-04-28 11:22
라인
Multinational drugmakers donated ₩30 billion last year
Twenty-eight multinational pharmaceutical companies operating in Korea dona...
by Kim Yun-mi
|
2020-04-23 15:09
라인
Samsung app wins nod for checking blood pressure on smartwatch
Samsung Electronics has won approval for its mobile application to measure ...
by Kim Yun-mi
|
2020-04-21 16:59
라인
Researchers to test asthma drug to treat Covid-19
Local infectious disease specialists said they would evaluate the potential...
by Kim Yun-mi
|
2020-04-16 16:20
라인
Opdivo’s indication expanded to esophageal squamous cell carcinoma
A new treatment option has become available in the local esophageal cancer ...
by Kim Yun-mi
|
2020-04-16 10:48
라인
Gilead revised clinical design of potential COVID-19 drug remdesivir. Why?
Gilead Sciences’ last-minute modification of the clinical design of remdesi...
by Kim Yun-mi
|
2020-04-10 15:36
라인
Review of cancer drug benefits delayed amid social distancing
The government has postponed the health authorities’ meeting for a review o...
by Kim Yun-mi
|
2020-04-08 13:46
라인
‘Computerized insulin infusion controls glucose faster, safer’
Local researchers said they have developed a computerized intravenous insul...
by Kim Yun-mi
|
2020-04-07 18:38
라인
Pfizer, MSD put off reorganizing due to COVID-19
Pfizer and MSD have postponed their scheduled organizational reshuffle beca...
by Kim Yun-mi
|
2020-04-03 17:09
라인
‘Early aspirin cut reduced bleeding in acute coronary syndrome patients’
Discontinuing aspirin was beneficial to prevent ischemic events and reduce ...
by Kim Yun-mi
|
2020-04-02 15:08
라인
Korea could lead global standard for infectious disease diagnosis
Korea is expected to lead the development of international standards for th...
by Kim Yun-mi
|
2020-03-30 16:03
라인
[Feature] Medical societies shift to online conferences in light of COVID-19
Medical societies at home and abroad, which had canceled or delayed annual ...
by Kim Yun-mi
|
2020-03-30 14:30
라인
2 drugmakers react differently to coronavirus pandemic
With the new coronavirus hitting the globe more extensively, a manufacturer...
by Kim Yun-mi
|
2020-03-26 13:36
-
1
2
3
4
5
6
7
8
9
10
다음
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top